Literature DB >> 25344852

[Ten years' experience in the research of abdominal compartment syndrome (2004-2014)].

Zsolt Bodnár1, Sándor Sipka2, Edit Tidrenczel3, Maria Amador Marchante1.   

Abstract

Intra-abdominal hypertension and abdominal compartment syndrome are frequent findings among severe surgical ill patients. In spite of the fast diagnostic methods and effective therapeutic procedures the mortality is high. The causing factors lead to increased intra-abdominal pressure and abdominal compartment syndrome. It can be defined as adverse physiologic consequences that occur as a result of an acute increase in the intra-abdominal pressure. The most common causes are retroperitoneal haemorrhage, pancreatitis, bowel obstruction, tense ascites, peritonitis and serious visceral edema due to massive fluid resuscitation. The affected systems are cardiovascular, respiratory, renal, central nervous systems, splanchnic organs, and finally the whole body. The diagnostic method is the intra-abdominal pressure monitoring. The bases of the treatment are adequate fluid resuscitation, non-surgical management and decompression. The authors review the topic including the international and Hungarian references based on their ten years experience.

Entities:  

Keywords:  abdominal compartment syndrome; adenosine; adenozin; hasi kompartmentszindróma; hasüregi hypertonia; hasüregi nyomás; hasüregi nyomásmérés; intra-abdominal pressure; intra-abdominal pressure measurement

Mesh:

Year:  2014        PMID: 25344852     DOI: 10.1556/OH.2014.30030

Source DB:  PubMed          Journal:  Orv Hetil        ISSN: 0030-6002            Impact factor:   0.540


  1 in total

Review 1.  Abdominal compartment syndrome due to extremely elongated sigmoid colon and rectum plus fecal impaction caused by disuse syndrome and diabetic neuropathy: a case report and review of the literature.

Authors:  Daisuke Usuda; Kohei Takanaga; Ryusho Sangen; Toshihiro Higashikawa; Shinichi Kinami; Hitoshi Saito; Yuji Kasamaki
Journal:  J Med Case Rep       Date:  2020-11-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.